Fluticasone furoate: all 116 studies that test it
Page 2 of 2. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Intranasal Steroids and the Nasal Ocular ResponseCompletedNCT00473915Phase 4
- Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.CompletedNCT00444509Phase 1
- Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver FunctionCompletedNCT00419237Phase 1
- A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.CompletedNCT00398645Phase 2
- Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- Long Term Safety Of GW685698X Via Nasal BiopsyCompletedNCT00224523Phase 3
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00116883Phase 3
- A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsCompletedNCT00116818Phase 3
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- Perennial Allergic Rhinitis Study In Pediatric SubjectsCompletedNCT00108914Phase 3
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
- A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3